SCHEMBL9517147

SCHEMBL9517147

Cc1ccc(NS(=O)(=O)c2cccc(F)c2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.54
KMT2A Q03164 2/20 0.52
SLC22A12 Q96S37 1/20 0.52
KIT P10721 2/20 0.51
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519540 0.84 MEN1 (0.63) KMT2ASLC22A12LMNASMN1; SMN2MEN1
SCHEMBL9517099 0.83 TSHR (0.69) PGRKMT2ASLC22A12LMNAHDAC1
SCHEMBL13807498 0.81 PGR (0.68) PGRKMT2ALMNASMN1; SMN2HDAC3
SCHEMBL23565665 0.80 KMT2A (0.71) PGRKMT2ALMNASMN1; SMN2MEN1
SCHEMBL95797 0.78 PGR (0.65) PGRKMT2ALMNASMN1; SMN2HDAC3
SCHEMBL17858628 0.78 SLC22A12 (0.54) PGRKMT2ASLC22A12KITLMNA
SCHEMBL13248875 0.77 KIT (0.46) PGRKMT2AKITLMNASMN1; SMN2
SCHEMBL1095392 0.75 SLC22A12 (0.60) SLC22A12
SCHEMBL19995039 0.75 KMT2A (0.55) PGRKMT2AKITLMNASMN1; SMN2
SCHEMBL9516051 0.75 PSEN1 (0.64) KMT2ASLC22A12KITLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed